Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Wow, wow
They were calm, professional, thorough, and incredibly compassionate
Researched For ARA-290 has been studied in rodent models of peripheral nerve injury, with researchers examining its interactions with small fiber neuropathy endpoints and nerve conduction parameters
The company's antibody-drug conjugate and bispecific antibody pipeline includes peptide-linker components, and its oncology focus positions it strongly in the Oncology Peptide Therapy segment (11.79% CAGR through 2031)
PMID: 42328738
Inducible nitric oxide synthase: An asset to neutrophils
US$ 24.66
US$ 27.25
US$ 24.85
US$ 20.20
US$ 29.95
